Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Talanta|December 11, 2019
Upconversion luminescence nanomaterials: A versatile platform for imaging, sensing, and therapyJun Yao, Cheng Huang, Chaohui Liu, et al.Frontiers in Medicine|July 30, 2025
Prognostic value of the lactate-to-albumin ratio in critically ill chronic heart failure patients with sepsis: insights from a retrospective cohort studyJunqi Gou, Chaohui Liu, Mingjian Lang, et al.Frontiers in Pharmacology|July 16, 2026
Intraoperative esketamine infusion and postoperative sleep quality after shoulder arthroscopy: a randomized controlled trialChaohui Liu, Wenying Lu, Lifeng Ni, et al.Nanoscale|December 10, 2025
Temperature-dependent electrochemical CO2-to-CO conversion on the bimetallic Ti-Ag nanoclusterBing Liu, Chaohui Liu, Peng Xiao, et al.Frontiers in Endocrinology|May 7, 2026
Multicenter cohort study reveals: composite inflammatory indexs are associated with increased risk of diabetes in patients with hypertensionFengyou Yao, Junqi Gou, Xiao Zhu, et al.Heliyon|December 27, 2023
Progress of near-infrared-II fluorescence in precision diagnosis and treatment of colorectal cancerYong Wu, Hongtao Cao, Shaoqing Yang, et al.Analytica Chimica Acta|April 28, 2019
Experimental and theoretical studies of a novel electrochemical sensor based on molecularly imprinted polymer and B, N, F-CQDs/AgNPs for enhanced specific identification and dual signal amplification in highly selective and ultra-trace bisphenol S determination in plastic productsJun Yao, Min Chen, Nannan Li, et al.Drug Design, Development and Therapy|June 3, 2026
Determining the Optimal Volume of Ropivacaine Combined with Dexmedetomidine for Programmed Intermittent Epidural Bolus in Labor Analgesia: A Randomized Dose-Response StudyCongzhong Song, Jianxin Ni, Chaohui Liu, et al.Drug Development Research|February 8, 2022
Daphnetin inhibits the survival of hepatocellular carcinoma cells through regulating Wnt/β-catenin signaling pathwayChaohui Liu, Jiansheng Pan, Hongyu Liu, et al.Scientific Reports|July 8, 2026
FTO-mediated m6A modification alleviates diabetic nephropathy progression by downregulating the CYP2J3/Smurf2 axisYinhao Liu, Chaohui Liu, Yuqing Chen, et al.Pageof 3